Literature DB >> 25376560

Differential expression of microRNAs and their target genes in non-small-cell lung cancer.

Hui-Young Lee1, Seon-Sook Han1, Hwanseok Rhee2, Jung Hoon Park2, Jae Seung Lee3, Yeon-Mok Oh3, Sun Shim Choi4, Seung-Ho Shin4, Woo Jin Kim1.   

Abstract

MicroRNAs (miRNAs) are single‑stranded RNA species that constitute a class of non‑coding RNAs, and are emerging as key regulators of gene expression. Since each miRNA is capable of regulating multiple genes, miRNAs are attractive markers for studies of coordinated gene expression. In this study, we investigated miRNA expression profiling using a massively parallel sequencing technique to compare non‑small‑cell lung cancer (NSCLC) tissue and normal lung tissue. Lung cancer tissue and normal lung tissue were obtained from nine NSCLC patients. RNA isolated from these samples was processed using RNA sequencing (RNA Seq) and the HiSeq 2000 system. Differentially expressed miRNAs and mRNAs were analyzed using a t‑test. We selected target pairs that showed a negative correlation among significantly differentially expressed miRNAs and their putative target mRNAs using miRBase Targets. The differences in the expression levels of 222 miRNAs and 1,597 genes were statistically significant, as indicated by an absolute fold change ≥1.5 and P<0.05. miR‑577, miR‑301b, miR‑944, miR‑891a and miR‑615‑3p were generally upregulated, and miR‑338‑3p was generally downregulated. miRNA‑mRNA target pair analysis revealed that 49 miRNAs had 696 target mRNAs. There were significantly differentially expressed miRNAs and mRNAs between lung cancer and normal tissue. Further investigation of miRNAs and their target genes is warranted to better understand NSCLC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25376560     DOI: 10.3892/mmr.2014.2890

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

1.  miR-873 induces lung adenocarcinoma cell proliferation and migration by targeting SRCIN1.

Authors:  Yushun Gao; Qi Xue; Dali Wang; Minjun Du; Yanjiao Zhang; Shugeng Gao
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

2.  MicroRNA-891a-5p is a novel biomarker for non-small cell lung cancer and targets HOXA5 to regulate tumor cell biological function.

Authors:  Nianqing Wan; Jianxiao Zheng
Journal:  Oncol Lett       Date:  2021-05-02       Impact factor: 2.967

3.  Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.

Authors:  Chunyu Li; Yunhong Yin; Xiao Liu; Xuejiao Xi; Weixiao Xue; Yiqing Qu
Journal:  Oncotarget       Date:  2017-04-11

4.  Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.

Authors:  Zhi-Peng Ren; Xiao-Bin Hou; Xiao-Dong Tian; Jun-Tang Guo; Lian-Bin Zhang; Zhi-Qiang Xue; Jian-Qing Deng; Shao-Wei Zhang; Jun-Yi Pan; Xiang-Yang Chu
Journal:  FEBS Open Bio       Date:  2019-01-09       Impact factor: 2.693

5.  miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway.

Authors:  Wu Yang; Wei Xiao; Zhengrong Cai; Shidai Jin; Tian Li
Journal:  Onco Targets Ther       Date:  2020-01-07       Impact factor: 4.147

6.  Smoking load reduction is insufficient to downregulate miR-301b, a lung cancer promoter.

Authors:  Camila Dos Santos Arcas; Hui Tzu Lin-Wang; Iracema Ioco Kikuchi Umeda; Márcio Gonçalves de Sousa; Daniela Mitiyo Odagiri Utiyama; Antonio de Padua Mansur; Mariangela Macchione; Mario Hiroyuki Hirata; Naomi Kondo Nakagawa
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

7.  Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq.

Authors:  Jae-Woong Min; Woo Jin Kim; Jeong A Han; Yu-Jin Jung; Kyu-Tae Kim; Woong-Yang Park; Hae-Ock Lee; Sun Shim Choi
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

8.  MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.

Authors:  Wanshuai Li; Yong Wang; Qi Zhang; Lili Tang; Xiaoping Liu; Yunhua Dai; Liang Xiao; Shuguang Huang; Lu Chen; Zhongmin Guo; Jim Lu; Kai Yuan
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

9.  Plasma CRABP2 as a Novel Biomarker in Patients with Non-Small Cell Lung Cancer.

Authors:  Do Jun Kim; Woo Jin Kim; Myoungnam Lim; Yoonki Hong; Seung-Joon Lee; Seok-Ho Hong; Jeongwon Heo; Hui-Young Lee; Seon-Sook Han
Journal:  J Korean Med Sci       Date:  2018-05-16       Impact factor: 2.153

10.  Integrative analysis of mRNA and miRNA expression profiles reveals seven potential diagnostic biomarkers for non‑small cell lung cancer.

Authors:  Jie Zhang; Dong Li; Yueming Zhang; Zongli Ding; Yulong Zheng; Song Chen; Yufeng Wan
Journal:  Oncol Rep       Date:  2019-11-13       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.